Evidence map›Paper›PMID 37346043›Full record

ArticleFrontiers in immunology2023

Gut epithelial barrier dysfunction in lupus triggers a differential humoral response against gut commensals.

María Botía-Sánchez, Georgina Galicia, Lorena Albaladejo-Marico, Daniel Toro-Domínguez, Maria Morell, Raquel Marcos-Fernández, Abelardo Margolles, Marta E Alarcón-Riquelme

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Frontiers in immunology · 2025
    Article
  7. Article
  8. Detection of Serum IgG Specific forVeterinary sciences · 2024
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

María Botía-SánchezGENYO, Center for Genomics and Oncological Research, Pfizer/University of Granada, Andalusian Government, Parque Tecnológico de la Salud, Granada, Spain.
Georgina GaliciaGENYO, Center for Genomics and Oncological Research, Pfizer/University of Granada, Andalusian Government, Parque Tecnológico de la Salud, Granada, Spain.
Lorena Albaladejo-MaricoGENYO, Center for Genomics and Oncological Research, Pfizer/University of Granada, Andalusian Government, Parque Tecnológico de la Salud, Granada, Spain.
Daniel Toro-DomínguezGENYO, Center for Genomics and Oncological Research, Pfizer/University of Granada, Andalusian Government, Parque Tecnológico de la Salud, Granada, Spain.
Maria MorellGENYO, Center for Genomics and Oncological Research, Pfizer/University of Granada, Andalusian Government, Parque Tecnológico de la Salud, Granada, Spain.
Raquel Marcos-FernándezDepartment of Microbiology and Biochemistry of Dairy Products, Instituto de Productos Lácteos de Asturias (IPLA), Consejo Superior de Investigaciones Científicas (CSIC), Villaviciosa, Asturias, Spain.
Abelardo MargollesDepartment of Microbiology and Biochemistry of Dairy Products, Instituto de Productos Lácteos de Asturias (IPLA), Consejo Superior de Investigaciones Científicas (CSIC), Villaviciosa, Asturias, Spain.
Marta E Alarcón-RiquelmeGENYO, Center for Genomics and Oncological Research, Pfizer/University of Granada, Andalusian Government, Parque Tecnológico de la Salud, Granada, Spain.
Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research · ESConsejo Superior de Investigaciones Científicas · ESParque Tecnológico de la Salud · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Systemic lupus erythematosus is an autoimmune disease with multisystemic involvement including intestinal inflammation. Lupus-associated intestinal inflammation may alter the mucosal barrier where millions of commensals have a dynamic and selective interaction with the host immune system. Here, we investigated the consequences of the intestinal inflammation in a TLR7-mediated lupus model. Methods: IgA humoral and cellular response in the gut was measured. The barrier function of the gut epithelial layer was characterised. Also, microbiota composition in the fecal matter was analysed as well as the systemic humoral response to differential commensals. Results: The lupus-associated intestinal inflammation modifies the IgA Discussion: Lupus development can cause alterations in microbiota composition, allowing specific species to colonize only the lupus gut. Eventually, these alterations and the changes in gut permeability induced by intestinal inflammation could lead to bacterial translocation.

Indexed as

Autoimmune DiseasesBacterial TranslocationB-LymphocytesHumansImmunoglobulin AInflammationImmunoglobulin Agut immune cellsintestinal permeabilityLupusmicrobiotaTLR7

Identifiers

PMID37346043
PMCPMC10280985
OpenAlexW4378234184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.